Latest lung disease News | Page 3

New computational method builds detailed maps of human tissues
Update on MESSINA Phase III trial for Fasenra in eosinophilic esophagitis
Cleaner emissions standards for trucks and buses
Changes to workplace exposure standard for respirable coal dust
New workplace coal dust standard commences in Queensland
ATAGI recommend Covid vaccination for some children aged 6 months to under 5 years
Children and high-risk populations immune responses to vaccinations and Covid going under microscope
World first online singing trial for people with chronic lung disease
Prestigious grant to profile responses to Covid vaccines in vulnerable people
Immunocompromised children under 5 now eligible for Covid vaccine
Treatment for fatal lung disease in babies closer
Enhertu significantly delayed disease progression in DESTINY-Breast02 Phase III trial vs. physician’s choice of treatment
Remembering Olivia Newton-John and Judith Durham – Aussie Queens of song
Datopotamab deruxtecan-based combinations show promising clinical activity
Enhertu approved in US as first HER2-directed therapy for patients with HER2-low metastatic breast cancer
Recruitment open for new study of lung disease
Enhertu granted Priority Review in US for patients with HER2-low metastatic breast cancer
AMA calls out Premier Palaszczuk for lack of consultation on pharmacy trial
QLD Premier must consult on pharmacy prescribing trial
Australia’s first national biotechnology incubator announces round one funding
Enhertu approved in EU for patients with HER2-positive metastatic breast cancer treated with one or more prior anti-HER2-based
Cynata Therapeutics secures US patent for Use of Cymerus MSCs in Asthma
Curtin University study backs AWU’s alarm at extent of workplace silicosis health risk
Mobile Health Unit at Opal Festival
Inhalable Covid Vaccine Shows Promise in Rodent Model
Top 3 questions – Oral Treatments for Covid with Dr Lucas de Toca
New drug target identified for inflammatory lung disease
Nuclear medicine funding a win for men with prostate cancer
Consultation Regulation Impact Statement: Managing risks of respirable crystalline silica at work
COPD patients respond equally well to Covid vaccine
Union shuts down major transmission line project to protect workers
Monash mRNA projects get funding boost
Addressing e-cigarette use among school children
New projects announced for National Drug Discovery Centre
Treatment hope for premature babies
Chronic lung disease treatment hits speed bump
Faster Diagnosis Possible In New Clinical Trial
Sleep relief for lung disease
Seventy-fifth World Health Assembly – Daily update 28 May
Influenza and Covid vaccination provide important protection this winter
Top 3 with Dr Lucas De Toca – Winter Preparedness
RACGP welcomes winter Covid booster expansion
Pandemic Science Hub to fight lung disease
PT027, novel fixed-dose combination of albuterol and budesonide, used as an as-needed rescue medicine
Cochrane Review highlights need for new interventions to improve chronic obstructive pulmonary disease
New VIC regulations against silicosis should be rolled out nationwide
Leveraging science of hibernation to improve human heart health
Weill Cornell instills social justice, health equity in medical education